286 related articles for article (PubMed ID: 26306748)
1. Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.
Aasebø E; Forthun RB; Berven F; Selheim F; Hernandez-Valladares M
Curr Pharm Biotechnol; 2016; 17(1):52-70. PubMed ID: 26306748
[TBL] [Abstract][Full Text] [Related]
2. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.
Aasebø E; Mjaavatten O; Vaudel M; Farag Y; Selheim F; Berven F; Bruserud Ø; Hernandez-Valladares M
J Proteomics; 2016 Aug; 145():214-225. PubMed ID: 27107777
[TBL] [Abstract][Full Text] [Related]
3. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
Hernandez-Valladares M; Bruserud Ø; Selheim F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
[TBL] [Abstract][Full Text] [Related]
4. Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia.
Hernandez-Valladares M; Aasebø E; Selheim F; Berven FS; Bruserud Ø
Proteomes; 2016 Aug; 4(3):. PubMed ID: 28248234
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.
Tong J; Helmy M; Cavalli FM; Jin L; St-Germain J; Karisch R; Taylor P; Minden MD; Taylor MD; Neel BG; Bader GD; Moran MF
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28176486
[TBL] [Abstract][Full Text] [Related]
6. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.
Hu CW; Qiu Y; Ligeralde A; Raybon AY; Yoo SY; Coombes KR; Qutub AA; Kornblau SM
Nat Biomed Eng; 2019 Nov; 3(11):889-901. PubMed ID: 30988472
[TBL] [Abstract][Full Text] [Related]
7. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.
Aasebø E; Vaudel M; Mjaavatten O; Gausdal G; Van der Burgh A; Gjertsen BT; Døskeland SO; Bruserud O; Berven FS; Selheim F
Proteomics; 2014 Sep; 14(17-18):1971-6. PubMed ID: 25044641
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
Strassberger V; Gutbrodt KL; Krall N; Roesli C; Takizawa H; Manz MG; Fugmann T; Neri D
J Proteomics; 2014 Mar; 99():138-51. PubMed ID: 24487095
[TBL] [Abstract][Full Text] [Related]
9. Construction of protein profile classification model and screening of proteomic signature of acute leukemia.
Xu Y; Zhuo J; Duan Y; Shi B; Chen X; Zhang X; Xiao L; Lou J; Huang R; Zhang Q; Du X; Li M; Wang D; Shi D
Int J Clin Exp Pathol; 2014; 7(9):5569-81. PubMed ID: 25337199
[TBL] [Abstract][Full Text] [Related]
10. Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action.
Hernandez-Valladares M; Wangen R; Berven FS; Guldbrandsen A
Curr Med Chem; 2019; 26(28):5317-5337. PubMed ID: 31241430
[TBL] [Abstract][Full Text] [Related]
11. Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.
Kaźmierczak M; Luczak M; Lewandowski K; Handschuh L; Czyż A; Jarmuż M; Gniot M; Michalak M; Figlerowicz M; Komarnicki M
Med Oncol; 2013 Dec; 30(4):725. PubMed ID: 24085543
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G
Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of proteomics between acute myeloid leukemia and acute lymphoid leukemia].
Xiao P; Zeng YY; Nie YF; Lin W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1353-6. PubMed ID: 22169282
[TBL] [Abstract][Full Text] [Related]
15. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
Kramer MH; Zhang Q; Sprung R; Day RB; Erdmann-Gilmore P; Li Y; Xu Z; Helton NM; George DR; Mi Y; Westervelt P; Payton JE; Ramakrishnan SM; Miller CA; Link DC; DiPersio JF; Walter MJ; Townsend RR; Ley TJ
Blood; 2022 Sep; 140(13):1533-1548. PubMed ID: 35895896
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
van Dijk AD; de Bont ESJM; Kornblau SM
Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303
[No Abstract] [Full Text] [Related]
17. Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.
Wojtuszkiewicz A; Schuurhuis GJ; Kessler FL; Piersma SR; Knol JC; Pham TV; Jansen G; Musters RJ; van Meerloo J; Assaraf YG; Kaspers GJ; Zweegman S; Cloos J; Jimenez CR
Mol Cell Proteomics; 2016 Apr; 15(4):1281-98. PubMed ID: 26801919
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.
Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR
PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100
[TBL] [Abstract][Full Text] [Related]
19. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia.
Kwak JY; Ma TZ; Yoo MJ; Choi BH; Kim HG; Kim SR; Yim CY; Kwak YG
Exp Hematol; 2004 Sep; 32(9):836-42. PubMed ID: 15345285
[TBL] [Abstract][Full Text] [Related]
20. Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.
Weber C; Schreiber TB; Daub H
J Proteomics; 2012 Feb; 75(4):1343-56. PubMed ID: 22115753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
